Update of the Dutch manual for costing studies in health care
- PMID: 29121647
- PMCID: PMC5679627
- DOI: 10.1371/journal.pone.0187477
Update of the Dutch manual for costing studies in health care
Abstract
Objectives: Dutch health economic guidelines include a costing manual, which describes preferred research methodology for costing studies and reference prices to ensure high quality studies and comparability between study outcomes. This paper describes the most important revisions of the costing manual compared to the previous version.
Methods: An online survey was sent out to potential users of the costing manual to identify topics for improvement. The costing manual was aligned with contemporary health economic guidelines. All methodology sections and parameter values needed for costing studies, particularly reference prices, were updated. An expert panel of health economists was consulted several times during the review process. The revised manual was reviewed by two members of the expert panel and by reviewers of the Dutch Health Care Institute.
Results: The majority of survey respondents was satisfied with content and usability of the existing costing manual. Respondents recommended updating reference prices and adding some particular commonly needed reference prices. Costs categories were adjusted to the international standard: 1) costs within the health care sector; 2) patient and family costs; and 3) costs in other sectors. Reference prices were updated to reflect 2014 values. The methodology chapter was rewritten to match the requirements of the costing manual and preferences of the users. Reference prices for nursing days of specific wards, for diagnostic procedures and nurse practitioners were added.
Conclusions: The usability of the costing manual was increased and parameter values were updated. The costing manual became integrated in the new health economic guidelines.
Conflict of interest statement
Similar articles
-
Standardisation of costs: the Dutch Manual for Costing in economic evaluations.Pharmacoeconomics. 2002;20(7):443-54. doi: 10.2165/00019053-200220070-00002. Pharmacoeconomics. 2002. PMID: 12093300
-
Update of the Dutch Manual for Costing in Economic Evaluations.Int J Technol Assess Health Care. 2012 Apr;28(2):152-8. doi: 10.1017/S0266462312000062. Int J Technol Assess Health Care. 2012. PMID: 22559757
-
Emergent Challenges in Determining Costs for Economic Evaluations.Pharmacoeconomics. 2017 Feb;35(2):129-139. doi: 10.1007/s40273-016-0465-1. Pharmacoeconomics. 2017. PMID: 27838912 Review.
-
Valuing inter-sectoral costs and benefits of interventions in the healthcare sector: methods for obtaining unit prices.Expert Rev Pharmacoecon Outcomes Res. 2017 Feb;17(1):77-84. doi: 10.1586/14737167.2016.1141679. Epub 2016 Feb 12. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 26757960
-
[Calculation of workers' health care costs].Med Pr. 2006;57(6):567-71. Med Pr. 2006. PMID: 17533995 Review. Polish.
Cited by
-
Dedicated MRI staging versus surgical staging of peritoneal metastases in colorectal cancer patients considered for CRS-HIPEC; the DISCO randomized multicenter trial.BMC Cancer. 2021 Apr 26;21(1):464. doi: 10.1186/s12885-021-08168-x. BMC Cancer. 2021. PMID: 33902498 Free PMC article. Clinical Trial.
-
Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE study.Front Neurol. 2022 Oct 28;13:1012486. doi: 10.3389/fneur.2022.1012486. eCollection 2022. Front Neurol. 2022. PMID: 36388190 Free PMC article.
-
Mobile Health App (AGRIPPA) to Prevent Relapse After Successful Interdisciplinary Treatment for Patients With Chronic Pain: Protocol for a Randomized Controlled Trial.JMIR Res Protoc. 2020 Aug 18;9(8):e18632. doi: 10.2196/18632. JMIR Res Protoc. 2020. PMID: 32808931 Free PMC article.
-
Cost-Utility of the eHealth Application 'Oncokompas', Supporting Incurably Ill Cancer Patients to Self-Manage Their Cancer-Related Symptoms: Results of a Randomized Controlled Trial.Curr Oncol. 2022 Aug 27;29(9):6186-6202. doi: 10.3390/curroncol29090486. Curr Oncol. 2022. PMID: 36135055 Free PMC article. Clinical Trial.
-
The Economic Costs of Informal Care: Estimates from a National Cross-Sectional Survey in The Netherlands.Eur J Health Econ. 2024 Nov;25(8):1311-1331. doi: 10.1007/s10198-023-01666-8. Epub 2024 Jan 31. Eur J Health Econ. 2024. PMID: 38294595 Free PMC article.
References
-
- Bracco A, Krol M. Economic evaluations in European reimbursement submission guidelines: current status and comparisons. Expert Rev Pharmacoecon Outcomes Res. 2013;13: 579–595. doi: 10.1586/14737167.2013.837766 - DOI - PubMed
-
- Zorginstituut Nederland. Guideline for conducting economic evaluations in healthcare [in Dutch: Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg]. 2016.
-
- Versteegh M, Knies S, Brouwer W. From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. Pharmacoeconomics. 2016: 1–4. - PubMed
-
- Tan SS, Bouwmans CAM, Rutten FFH, Hakkaart-van Roijen L. Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care. 2012;28: 152–158. doi: 10.1017/S0266462312000062 - DOI - PubMed
-
- Tan SS, Rutten FFH, Van Ineveld BM, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10: 39–45. doi: 10.1007/s10198-008-0101-x - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources